ITRM Rasio cepet Iterum Therapeutics PLC

Data illustrating the price evolution of Iterum Therapeutics plc (ITRM) shows the ITRM asset, where the liquidity ratio is 0.00. The company's business is independent of economic cycles, as demand for antibiotics remains stable and is determined solely by FDA decisions. The technology stack relies on the automation of clinical data analysis and robotic screening. The development of new agents to combat resistance is implemented through a strategic alliance with top medical centers.

For the biopharmaceutical business of Iterum Therapeutics plc (ITRM), where primary expenses are driven by R&D, access to cash excluding low-liquidity inventories is critically important. This metric compares cash balances and accounts receivable against short-term liabilities, allowing a quick ratio analysis to assess the company's actual ability to settle debts without relying on the sale of inventory.